Andy Rittenberg
Chief Legal OfficerMr. Andy Rittenberg is Chief Legal Officer of Coherus Oncology, Inc. (formerly known as Coherus BioSciences, Inc.) since 2026 and had been its Executive Vice President of General Counsel from April 2024 until 2026. He brings to Coherus providing legal support for pharmaceutical and biotechnology companies as both in-house and outside counsel. Prior to joining Coherus, he served as Senior Vice President Legal and Chief Compliance Officer for Gilead Sciences, Inc. Over more than 17 years at Gilead, he played a foundational role in developing Gilead?s global legal team, supporting the commercialization of over a dozen highly successful pharmaceutical products and providing solutions for difficult legal, regulatory and business challenges. Prior to Gilead, he was an attorney with Covington & Burling, where he focused on commercial litigation, government and internal investigations and False Claims Act litigation. He previously worked on health care reform initiatives in the White House and Treasury Department. He has a B. A. from Yale University and earned his law degree from the University of Chicago.
Positions
- Company NameCoherus Oncology, Inc.Stock CodeCHRSPositionChief Legal OfficerColleagues
- DMDennis M. LanfearChairman, President & CEO
- BJBryan J. McMichaelChief Financial Officer
- CGCarrie GrahamVice President of Investor Relations & Advocacy
- RSRebecca SunshineChief Human Resources Officer
- TMTheresa M. LavalleeChief Development Officer & Chairman of Scientific Advisory Board
- AJAli J. SatvatIndependent Director
- CWCharles W. NewtonIndependent Director
- RARita A. KarachunIndependent Director
